2023 - Research.com Medicine in Canada Leader Award
2019 - Fellow of the Royal Society of Canada Academy of Science
Cancer, Cancer research, Pathology, Ovarian cancer and Breast cancer are his primary areas of study. His Cancer research incorporates elements of Mutation and Hereditary diffuse gastric cancer. His biological study spans a wide range of topics, including Genetics, Carcinogenesis, Fusion gene, Immunology and PTEN.
David G. Huntsman combines subjects such as Serous fluid, Gynecology, microRNA, Disease and Gene duplication with his study of Ovarian cancer. The concepts of his Serous fluid study are interwoven with issues in Serous carcinoma, Carcinoma, Clear cell, Ovarian carcinoma and Fallopian tube. The Breast cancer study combines topics in areas such as Penetrance, Oncology and Bioinformatics.
David G. Huntsman mainly focuses on Pathology, Cancer research, Cancer, Internal medicine and Ovarian cancer. His work deals with themes such as Adenocarcinoma and Ovary, which intersect with Pathology. His Cancer research study combines topics in areas such as SMARCA4, Somatic cell, Carcinogenesis, KRAS and Epigenetics.
His Cancer study integrates concerns from other disciplines, such as Mutation, Genetic counseling, Bioinformatics and Hereditary diffuse gastric cancer. His Oncology research extends to Internal medicine, which is thematically connected. David G. Huntsman has researched Ovarian cancer in several fields, including Endometriosis, Molecular biology and Serous fluid.
David G. Huntsman mostly deals with Cancer research, Internal medicine, Ovarian cancer, Cancer and Oncology. His Cancer research study combines topics from a wide range of disciplines, such as Immunohistochemistry, Cell, Carcinogenesis, Mutation and Nonsense mutation. His Ovarian cancer research incorporates themes from Cancer cell, Immune system and Chemotherapy.
His studies deal with areas such as Germline and Hereditary diffuse gastric cancer as well as Cancer. His Oncology research is multidisciplinary, relying on both Ovarian carcinoma, Serous fluid, Concordance, Ovarian tumor and Hazard ratio. His work carried out in the field of Serous fluid brings together such families of science as Tissue microarray, Serous carcinoma and Clear cell.
His main research concerns Cancer research, Internal medicine, Oncology, Germline mutation and Carcinoma. His study in Cancer research is interdisciplinary in nature, drawing from both DNA methylation, Carcinogenesis, Ovarian cancer, Regulation of gene expression and Epigenetics. The study incorporates disciplines such as Immunohistochemistry, Tissue microarray, Endometrial cancer and Cohort in addition to Carcinoma.
David G. Huntsman works mostly in the field of Immunohistochemistry, limiting it down to concerns involving PAX8 and, occasionally, Pathology. David G. Huntsman studies Breast cancer which is a part of Cancer. His Ovarian tumor research focuses on Serous fluid and how it connects with Serous carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated genomic analyses of ovarian carcinoma
D. Bell;A. Berchuck;M. Birrer;J. Chien.
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi.
ARID1A mutations in endometriosis-associated ovarian carcinomas.
Kimberly C. Wiegand;Sohrab P. Shah;Osama M. Al-Agha;Yongjun Zhao.
The New England Journal of Medicine (2010)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A Gelmon;Marc Tischkowitz;Helen Mackay;Kenneth Swenerton.
Lancet Oncology (2011)
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks.
PLOS Medicine (2010)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah;Ryan D. Morin;Jaswinder Khattra;Leah Prentice.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee.
Lancet Oncology (2012)
Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer
David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria.
Nature Reviews Cancer (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: